Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study
Sponsor: University Medical Centre Ljubljana
Summary
The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.
Official title: Effect of Cerebrolysin on Early Rehabilitation After Ischemic Stroke at the Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT), University Medical Centre Ljubljana
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-06-13
Completion Date
2027-10-15
Last Updated
2025-07-09
Healthy Volunteers
No
Interventions
Cerebrolysin treatment
The patients will receive Cerebrolysin treatment, 10 days consecutively, 30 ml/day, intravenous infusion diluted up to 100 ml of 0.9% saline in 15 minutes.
Standard treatment (including neurorehabilitation) of acute ischemic stroke
"Standard treatment" entails acute ischemic stroke reperfusion treatment according to international guidelines and local policies, instituting secondary preventive treatment, a proper management of stroke risk factors and neurorehabilitation according to patient's needs: locomotor physiotherapy, occupation therapy, speech therapy, and neuropsychological assessment.
Locations (1)
UMC Ljubljana - Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT)
Ljubljana, Slovenia